Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20061
20112
20121
20131
20142
20151
20162
20182
20192
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status4
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Basilea Pharmaceutica1
Enterome1
European Organisation for Research and Treatment of Cancer - EORTC1
Heidelberg University1
INSYS Therapeutics Inc1
Medical Research Council1
Novartis Pharmaceuticals1
Oryx GmbH & Co. KG1
PharmaMar1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma21
Glioma5
Brain Neoplasms3
Gliosarcoma3
Neoplasms3
Astrocytoma1
Carcinoma, Ovarian Epithelial1
Central Nervous System Neoplasms1
Colorectal Neoplasms1
Diffuse Intrinsic Pontine Glioma1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.